Tags: charles riverRemove, financeRemove, pharmaceuticalsRemove

M&A
Pharmaceutical research company Charles River pays $1.6 billion in cash and stock to acquire Chinese outsourcing company WuXi PharmaTech two-and-a-half years after its listing ...
By Sameera Anand | 27 April 2010
Tag Filters
WEBCASTS
On Demand Webcasts
Magazine
FinanceAsia Magazine
FinanceAsia
May 2012